# A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye

> **NCT05411367** · PHASE3 · COMPLETED · sponsor: **Seikagaku Corporation** · enrollment: 232 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** SI-614
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05411367
- **Lead sponsor:** Seikagaku Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-28
- **Primary completion:** 2023-03-02
- **Final completion:** 2023-04-27
- **Target enrollment:** 232 (ACTUAL)
- **Last updated:** 2026-01-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05411367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05411367, "A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05411367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*